The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Myocarditis (can be fulminant)
See PMID 34514306
Publications
Post-vaccine COVID-19 acute myocarditis: case reports and literature review.
The Pan African medical journal. 2023;44:192
Goddard K, Lewis N, Fireman B, Weintraub E, Shimabukuro T, Zerbo O, Boyce TG, Oster ME, Hanson KE, Donahue JG, Ross P, Naleway A, Nelson JC, Lewin B, Glanz JM, Williams JTB, Kharbanda EO, Katherine Yih W, Klein NP
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.
Vaccine. 2022;40(35):5153-5159
A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination.
Journal of Korean medical science. 2022;37(13):e104
Transient Myopericarditis Following Vaccination for COVID-19.
Journal of medical cases. 2022;13(2):80-84
Parmar K, Mekraksakit P, Del Rio-Pertuz G, Sethi P, Motes A, Hughes M, Wischmeyer J, Carbajal L, Sosa EA
Myocarditis following COVID-19 mRNA vaccination.
Proceedings (Baylor University. Medical Center). 2022;35(2):209-213
Myocarditis post-SARS-CoV-2 vaccination: a systematic review.
QJM : monthly journal of the Association of Physicians. 2023;116(1):7-25
Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020-October 2021).
Heart, lung & circulation. 2022;31(6):757-765
A report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination.
European heart journal. Case reports. 2022;6(1):ytac004
Fulminant myocarditis after the second dose of COVID-19 mRNA vaccination.
Clinical case reports. 2022;10(2):e05378
Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis.
Frontiers in cardiovascular medicine. 2021;8:769616
Naghashzadeh F, Shafaghi S, Dorudinia A, Naji SA, Marjani M, Amin A, Mohamadifar A, Noorali S, Kashani BS
Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: case report.
ESC heart failure. 2022;9(2):1483-1486
First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain.
Cureus. 2021;13(12):e20313
Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine.
European heart journal. Case reports. 2021;5(8):ytab319
Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients.
International journal of cardiology. 2021;340:119-121
Myocarditis With COVID-19 mRNA Vaccines.
Circulation. 2021;144(6):471-484
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines.
Cureus. 2021;13(6):e15576
COVID-19 mRNA Vaccine and Myocarditis.
European journal of case reports in internal medicine. 2021;8(7):002681
Acute myocarditis following administration of BNT162b2 vaccine.
IDCases. 2021;25:e01197
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines.
JAMA cardiology. 2021;6(10):1115-1117
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
JAMA cardiology. 2021;6(10):1196-1201
Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?
BMJ (Clinical research ed.). 2021;373:n1635
Larson KF, Ammirati E, Adler ED, Cooper LT Jr, Hong KN, Saponara G, Couri D, Cereda A, Procopio A, Cavalotti C, Oliva F, Sanna T, Ciconte VA, Onyango G, Holmes DR, Borgeson DD
Myocarditis After BNT162b2 and mRNA-1273 Vaccination.
Circulation. 2021;144(6):506-508